CO5640141A2 - Composicion que comprende extractos de panax ginseg y paulli nia cupana - Google Patents
Composicion que comprende extractos de panax ginseg y paulli nia cupanaInfo
- Publication number
- CO5640141A2 CO5640141A2 CO05039563A CO05039563A CO5640141A2 CO 5640141 A2 CO5640141 A2 CO 5640141A2 CO 05039563 A CO05039563 A CO 05039563A CO 05039563 A CO05039563 A CO 05039563A CO 5640141 A2 CO5640141 A2 CO 5640141A2
- Authority
- CO
- Colombia
- Prior art keywords
- vitamin
- composition
- extract
- cupana
- paulli
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 235000002791 Panax Nutrition 0.000 title 1
- 241000208343 Panax Species 0.000 title 1
- 235000020733 paullinia cupana extract Nutrition 0.000 title 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 2
- 240000004371 Panax ginseng Species 0.000 abstract 2
- 240000003444 Paullinia cupana Species 0.000 abstract 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract 2
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 2
- 239000011707 mineral Substances 0.000 abstract 2
- 235000010755 mineral Nutrition 0.000 abstract 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 2
- 239000011573 trace mineral Substances 0.000 abstract 2
- 235000013619 trace mineral Nutrition 0.000 abstract 2
- 229930003231 vitamin Natural products 0.000 abstract 2
- 235000013343 vitamin Nutrition 0.000 abstract 2
- 239000011782 vitamin Substances 0.000 abstract 2
- 229940088594 vitamin Drugs 0.000 abstract 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 abstract 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 abstract 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 abstract 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract 1
- 229930003451 Vitamin B1 Natural products 0.000 abstract 1
- 229930003779 Vitamin B12 Natural products 0.000 abstract 1
- 229930003471 Vitamin B2 Natural products 0.000 abstract 1
- 229930003268 Vitamin C Natural products 0.000 abstract 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 1
- 229960002685 biotin Drugs 0.000 abstract 1
- 235000020958 biotin Nutrition 0.000 abstract 1
- 239000011616 biotin Substances 0.000 abstract 1
- 229960001948 caffeine Drugs 0.000 abstract 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 1
- 230000003930 cognitive ability Effects 0.000 abstract 1
- 229910052802 copper Inorganic materials 0.000 abstract 1
- 239000010949 copper Substances 0.000 abstract 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 1
- 229960000304 folic acid Drugs 0.000 abstract 1
- 235000019152 folic acid Nutrition 0.000 abstract 1
- 239000011724 folic acid Substances 0.000 abstract 1
- 229930182494 ginsenoside Natural products 0.000 abstract 1
- 229910052742 iron Inorganic materials 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 239000011574 phosphorus Substances 0.000 abstract 1
- 229910052698 phosphorus Inorganic materials 0.000 abstract 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 1
- 229960002477 riboflavin Drugs 0.000 abstract 1
- 239000011669 selenium Substances 0.000 abstract 1
- 229910052711 selenium Inorganic materials 0.000 abstract 1
- 229960003495 thiamine Drugs 0.000 abstract 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 abstract 1
- 235000010374 vitamin B1 Nutrition 0.000 abstract 1
- 239000011691 vitamin B1 Substances 0.000 abstract 1
- 235000019163 vitamin B12 Nutrition 0.000 abstract 1
- 239000011715 vitamin B12 Substances 0.000 abstract 1
- 235000019164 vitamin B2 Nutrition 0.000 abstract 1
- 239000011716 vitamin B2 Substances 0.000 abstract 1
- 235000019160 vitamin B3 Nutrition 0.000 abstract 1
- 239000011708 vitamin B3 Substances 0.000 abstract 1
- 235000019158 vitamin B6 Nutrition 0.000 abstract 1
- 239000011726 vitamin B6 Substances 0.000 abstract 1
- 235000019154 vitamin C Nutrition 0.000 abstract 1
- 239000011718 vitamin C Substances 0.000 abstract 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 abstract 1
- 235000005282 vitamin D3 Nutrition 0.000 abstract 1
- 239000011647 vitamin D3 Substances 0.000 abstract 1
- 229940011671 vitamin b6 Drugs 0.000 abstract 1
- 229940021056 vitamin d3 Drugs 0.000 abstract 1
- 239000011701 zinc Substances 0.000 abstract 1
- 229910052725 zinc Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/60—Edible seaweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Botany (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Microbiology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Psychiatry (AREA)
- Alternative & Traditional Medicine (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
Abstract
1.- Un método para mejorar las habilidades cognitivas de una persona mediante la administración de una composición que comprende una cantidad sinérgicamente eficaz de un extracto de la planta Panax ginseng; y una cantidad sinérgicamente eficaz de un extracto de la planta Paullinia cupana.2.- Un método de acuerdo con la reivindicación 1, en el que dicha composición además comprende una o más vitaminas; y uno o más minerales y/o elementos traza.3.- Un método de acuerdo con la reivindicación 1 ó 2, en el que dicho extracto de la planta Panax ginseng contiene al menos un 3% de ginsenósidos.4.- Un método de acuerdo con cualquiera de las reivindicaciones precedentes, en el que dicho extracto de la planta Paullinia cupana contiene hasta un 12% de cafeína. 5.- Un método de acuerdo con cualquiera de las reivindicaciones precedentes, en el que dichas una o más vitaminas (iii) son seleccionadas del grupo que consiste en ProVitamina A, Vitamina B1, Vitamina B2, Vitamina B6, Vitamina B12, Vitamina C, Vitamina D3, d,l-alfa-Tocoferolacetato, Ácido Fólico, Biotina y Vitamina PP.6.- Un método de acuerdo con cualquiera de las reivindicaciones precedentes, en el que dichos uno o más minerales y/o elementos traza (iv) son seleccionados del grupo que consiste en Cobre, Calcio, Hierro, Cinc, Selenio, Fósforo y Magnesio.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE20215011U DE20215011U1 (de) | 2002-09-28 | 2002-09-28 | Nahrungsergänzungsmittel bzw. Energiemix, auf der Basis von Vitaminen, Mineralstoffen, Spurenelementen und Koffein in Form eines Guarana-Extrakts, welches grundsätzlich in einer Tagesdosis verpackt ist |
| EP03005568A EP1457209A1 (en) | 2003-03-12 | 2003-03-12 | Composition for the enhancement of cognitive skills comprising Panax ginseng and Paullinia cupana extracts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5640141A2 true CO5640141A2 (es) | 2006-05-31 |
Family
ID=32044192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO05039563A CO5640141A2 (es) | 2002-09-28 | 2005-04-26 | Composicion que comprende extractos de panax ginseg y paulli nia cupana |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20050202104A1 (es) |
| EP (1) | EP1545569B1 (es) |
| JP (1) | JP2006503844A (es) |
| KR (1) | KR20050047130A (es) |
| CN (1) | CN100411655C (es) |
| AU (1) | AU2003267419B2 (es) |
| BR (1) | BR0314964A (es) |
| CA (1) | CA2500154C (es) |
| CO (1) | CO5640141A2 (es) |
| EC (1) | ECSP055706A (es) |
| HK (1) | HK1084868A1 (es) |
| MX (1) | MXPA05003285A (es) |
| NZ (2) | NZ539658A (es) |
| PL (1) | PL218910B1 (es) |
| RU (2) | RU2355192C2 (es) |
| WO (1) | WO2004028550A2 (es) |
| ZA (1) | ZA200502030B (es) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2882896B1 (fr) * | 2005-03-14 | 2007-05-04 | Larena Sa | Composition alimentaire pour prevenir le syndrome de fragilite chez les personnes agees |
| CN100475273C (zh) * | 2007-01-08 | 2009-04-08 | 广东省微生物研究所 | 一种室内空气消毒剂 |
| KR20080105470A (ko) * | 2007-05-31 | 2008-12-04 | (주)아모레퍼시픽 | 인삼 열매 추출물을 함유하는 비만 예방 및 개선용 식품조성물 |
| US20090155392A1 (en) * | 2007-12-17 | 2009-06-18 | Bret David Nelson | Methods and Systems for Sublingual Guarana Administration |
| BRPI1101146A2 (pt) | 2011-03-31 | 2013-05-28 | Luiz Francisco Pianowski | fraÇço ativa de paullinia cupana com atividade aprimorada no combate À fadiga, processo de produÇço de uma fraÇço ativa, uso, composiÇço farmacÊutica, medicamento e mÉtodo de tratamento de fadiga |
| US8840937B2 (en) * | 2011-08-02 | 2014-09-23 | Walter Joe FORD, JR. | Composition and method for recovery from mild traumatic brain injury |
| JP6072004B2 (ja) * | 2012-03-28 | 2017-02-01 | 大幸薬品株式会社 | 薬剤組成物、及びこれを密封してなる軟カプセル剤 |
| US9974823B2 (en) * | 2012-06-13 | 2018-05-22 | Inno-Bev Ltd. | Composition comprising natural extracts |
| FR3025700B1 (fr) | 2014-09-12 | 2016-11-04 | Bruno Obriot | Procede de fabrication d'un complement alimentaire a base d'huiles essentielles en poudre |
| KR20180059390A (ko) * | 2014-10-31 | 2018-06-04 | 스페리움 바이오메드 에스.엘. | 근육통과 관련된 상태의 치료를 위한 배합물 |
| RU2635573C1 (ru) * | 2016-10-31 | 2017-11-14 | Василий Григорьевич Густинович | Пищевая добавка |
| IT201700123873A1 (it) * | 2017-10-31 | 2019-05-01 | Erba Vita Group S P A | Una bibita comprendente ingredienti solo di origine naturale |
| RU2679634C1 (ru) * | 2018-09-07 | 2019-02-12 | Федеральное государственное автономное образовательное учреждение высшего образования "Дальневосточный федеральный университет" (ДВФУ) | Способ получения СО2 экстракта женьшеня |
| WO2020209427A1 (ko) * | 2019-04-12 | 2020-10-15 | 주식회사 비엔지삶 | 팔미라팜, 인삼, 및 아티초크를 유효성분으로 포함하는 식품 조성물, 이를 이용한 발포정, 및 이의 제조방법 |
| KR20220041655A (ko) | 2020-09-25 | 2022-04-01 | 경희대학교 산학협력단 | 미삼 농축추출물을 이용한 인지능력 및 기억력 개선용 조성물 및 이의 제조방법 |
| KR20220041656A (ko) | 2020-09-25 | 2022-04-01 | 경희대학교 산학협력단 | 미삼 나노분쇄액 동결건조분말을 이용한 인지능력 및 기억력 개선용 조성물 및 그 제조방법 |
| KR102284681B1 (ko) | 2020-10-27 | 2021-07-30 | 윤정희 | 미삼을 이용한 부대찌개 소스 및 그의 제조방법 |
| RU2764076C1 (ru) * | 2021-06-03 | 2022-01-13 | Общество с ограниченной ответственностью "Академия-Т" | Биологически активная добавка к пище |
| MX2024000140A (es) * | 2021-06-25 | 2024-02-13 | Coca Cola Co | Composición consumible por vía oral con extracto de plantas. |
| CA3241543A1 (en) * | 2022-03-24 | 2023-09-28 | Eleanor DUFF | Adaptogen formulations and methods of use |
| WO2023242296A1 (fr) * | 2022-06-16 | 2023-12-21 | Microphyt | Utilisation d'un extrait de microalgue seul ou en combinaison pour ameliorer les capacites cognitives |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4935243A (en) * | 1988-12-19 | 1990-06-19 | Pharmacaps, Inc. | Chewable, edible soft gelatin capsule |
| JP2869991B2 (ja) * | 1989-01-30 | 1999-03-10 | トヨタ自動車株式会社 | Ｆｍｓラインにおける生産指示方法およびその装置 |
| JPH05213763A (ja) * | 1992-02-10 | 1993-08-24 | Sanwa Kagaku Kenkyusho Co Ltd | 易吸収活性化カルシウム製剤 |
| LU88375A1 (fr) * | 1993-07-12 | 1994-04-01 | Michel Urso Prof Medecin Et Ch | Produit énergétique stimulant la puissance virile |
| FR2712191B1 (fr) * | 1993-11-08 | 1996-03-08 | Bioes Laboratoires | Composition pharmaceutique ou diététique associant du ginseng et du guarana. |
| GB2285578A (en) * | 1993-12-22 | 1995-07-19 | Leilani Lea | Beverages containing added guaranine |
| CN1131521A (zh) * | 1995-12-04 | 1996-09-25 | 蔡东明 | 草珊瑚清凉饮料配方及其制备工艺 |
| IT1293539B1 (it) * | 1997-07-16 | 1999-03-01 | Sigma Tau Ind Farmaceuti | Composizione nutritiva per soggetti in stato di debilitazione causato da stress |
| US5925377A (en) * | 1997-08-07 | 1999-07-20 | Nova Pharmaceutical Co. | Dietary supplement composition |
| US5945107A (en) * | 1997-12-08 | 1999-08-31 | Natural Medio Tech A/S | Compositions and methods for weight reduction |
| TWI247585B (en) * | 1999-05-14 | 2006-01-21 | Takara Bio Inc | Agarobiose-containing composition |
| AU6020700A (en) * | 1999-07-19 | 2001-02-05 | Kyowa Hakko Kogyo Co. Ltd. | Feeds and foods for treating or preventig disease accompanying aging, method forfeeding klotho mutant homoanimal and feeds therefor |
| WO2001021147A1 (en) * | 1999-09-20 | 2001-03-29 | Mastercare | Diet and weight control gum and sucker |
| EP1242105B3 (en) * | 1999-12-17 | 2009-08-12 | Pharmaton S.A. | Combination of ginseng and ginkgo to improve cognitive skills |
| US6399116B1 (en) * | 2000-04-28 | 2002-06-04 | Rulin Xiu | Rhodiola and used thereof |
| DE10027968A1 (de) * | 2000-06-08 | 2001-12-13 | Asta Medica Ag | Mittel zur Therapie von Demenzen |
| JP2002029981A (ja) * | 2000-07-13 | 2002-01-29 | Mie Kariyou Kk | 向知性素材 |
| DE10140320A1 (de) * | 2001-08-16 | 2003-03-06 | Udo Zirfas | Potenzfördernder und vitaltonisierender Wirkstoff |
-
2003
- 2003-09-26 RU RU2005113164/13A patent/RU2355192C2/ru not_active IP Right Cessation
- 2003-09-26 CN CNB038231905A patent/CN100411655C/zh not_active Expired - Lifetime
- 2003-09-26 KR KR1020057005301A patent/KR20050047130A/ko not_active Application Discontinuation
- 2003-09-26 CA CA2500154A patent/CA2500154C/en not_active Expired - Fee Related
- 2003-09-26 BR BR0314964-1A patent/BR0314964A/pt not_active Application Discontinuation
- 2003-09-26 WO PCT/EP2003/010749 patent/WO2004028550A2/en active Application Filing
- 2003-09-26 MX MXPA05003285A patent/MXPA05003285A/es active IP Right Grant
- 2003-09-26 PL PL374950A patent/PL218910B1/pl unknown
- 2003-09-26 JP JP2004539046A patent/JP2006503844A/ja active Pending
- 2003-09-26 EP EP03748100.9A patent/EP1545569B1/en not_active Expired - Lifetime
- 2003-09-26 AU AU2003267419A patent/AU2003267419B2/en not_active Ceased
- 2003-09-26 NZ NZ539658A patent/NZ539658A/en not_active IP Right Cessation
-
2005
- 2005-03-10 ZA ZA2005/02030A patent/ZA200502030B/en unknown
- 2005-03-24 US US11/089,260 patent/US20050202104A1/en not_active Abandoned
- 2005-03-28 EC EC2005005706A patent/ECSP055706A/es unknown
- 2005-04-26 CO CO05039563A patent/CO5640141A2/es not_active Application Discontinuation
-
2006
- 2006-03-17 HK HK06103372A patent/HK1084868A1/xx not_active IP Right Cessation
-
2007
- 2007-01-18 NZ NZ552688A patent/NZ552688A/en not_active IP Right Cessation
-
2008
- 2008-03-13 RU RU2008109312/13A patent/RU2008109312A/ru not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA05003285A (es) | 2005-07-05 |
| CN1684698A (zh) | 2005-10-19 |
| KR20050047130A (ko) | 2005-05-19 |
| HK1084868A1 (en) | 2006-08-11 |
| EP1545569B1 (en) | 2016-12-14 |
| NZ552688A (en) | 2008-11-28 |
| CA2500154A1 (en) | 2004-04-08 |
| WO2004028550A2 (en) | 2004-04-08 |
| RU2008109312A (ru) | 2009-09-20 |
| EP1545569A2 (en) | 2005-06-29 |
| CN100411655C (zh) | 2008-08-20 |
| ZA200502030B (en) | 2005-11-30 |
| AU2003267419A1 (en) | 2004-04-19 |
| ECSP055706A (es) | 2005-08-11 |
| PL218910B1 (pl) | 2015-02-27 |
| US20050202104A1 (en) | 2005-09-15 |
| JP2006503844A (ja) | 2006-02-02 |
| PL374950A1 (en) | 2005-11-14 |
| CA2500154C (en) | 2019-01-15 |
| AU2003267419B2 (en) | 2009-07-02 |
| RU2355192C2 (ru) | 2009-05-20 |
| BR0314964A (pt) | 2005-08-02 |
| RU2005113164A (ru) | 2006-01-27 |
| WO2004028550A3 (en) | 2004-06-10 |
| NZ539658A (en) | 2007-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5640141A2 (es) | Composicion que comprende extractos de panax ginseg y paulli nia cupana | |
| WO2006015154A3 (en) | Compositions and methods for nutrition supplementation | |
| WO2007047327A3 (en) | Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency | |
| AR009037A1 (es) | Un suplemento dietario para proveer un producto nutricional de sacaridos que son componentes esenciales de las glicoproteinas de los mamiferos | |
| BR112015004520A2 (pt) | método de extração | |
| CY1112547T1 (el) | Μεσα που περιεχουν φολικο οξυ, βιταμινη β6 και βιταμινη β12, και η χρηση αυτων | |
| WO2007076416A3 (en) | Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision | |
| WO2003013270A3 (en) | Calcium dietary supplement | |
| WO2008051594A3 (en) | Anti-resorptive and bone building dietary supplements and methods of use | |
| WO2006063443A3 (en) | Supplement dietary composition for promoting weight loss | |
| JP2006503844A5 (es) | ||
| MX2020002314A (es) | Suplementos nutricionales que afectan el equilibrio del eje intestino-cerebro y el bienestar mental. | |
| DE202007019158U1 (de) | Vorrichtung zur Durchführung eines kosmetischen Verfahrens zur Beeinflussung der Haut | |
| PE20041027A1 (es) | Composicion que comprende panax ginseng | |
| US20100291157A1 (en) | Composition for headache treatment | |
| WO2007050599A8 (en) | Ginkgolides in the treatment and prevention of ovarian cancer | |
| Novita et al. | Effect of anthocyanin to post-orthodontic treatment: a review | |
| CN106723066A (zh) | 一种硼硒和多种维生素复合添加剂 | |
| Jamdar et al. | Reduction in tibial shaft fracture healing time with essential nutrient supplementation containing ascorbic acid, lysine, and proline | |
| ATE462309T1 (de) | Zusammensetzung zur aktivierung des immunsystems | |
| US8889157B1 (en) | Composition for cardiovascular treatment | |
| UA86579C2 (ru) | Применение композиции, которая содержит экстракты растений panax ginseng и paullinia cupana | |
| PH12020500147A1 (en) | Compositions and methods for the treatment and prevention of cognitive decline and preservation of neuronal function | |
| CN109965289A (zh) | 一种促生长配方 | |
| MX2022010361A (es) | Composicion de suplementos dieteticos y nutricionales para incrementar el potencial fertil en hombres. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |